Unknown

Dataset Information

0

Complete metabolic response of metastatic castration-resistant neuroendocrine carcinoma of the prostate after treatment with RRx-001 and reintroduced platinum doublets.


ABSTRACT: Presented herein is the case of a heavily pretreated patient with high-grade neuroendocrine prostate cancer that achieved a complete metabolic response on platinum-based chemotherapy after treatment with the dual CD-47 and SIRP-? inhibitor, RRx-001, in a Phase II clinical trial.

SUBMITTER: Ojemuyiwa M 

PROVIDER: S-EPMC6293266 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Complete metabolic response of metastatic castration-resistant neuroendocrine carcinoma of the prostate after treatment with RRx-001 and reintroduced platinum doublets.

Ojemuyiwa Michelle M   Zeman Karen K   Spira Alexander A   Oronsky Bryan B   Ray Carolyn C   Trepel Jane B JB   Lee Min-Jung MJ   Onyiuke Ifeyinwa I   Brzezniak Christina C  

Clinical case reports 20181105 12


Presented herein is the case of a heavily pretreated patient with high-grade neuroendocrine prostate cancer that achieved a complete metabolic response on platinum-based chemotherapy after treatment with the dual CD-47 and SIRP-α inhibitor, RRx-001, in a Phase II clinical trial. ...[more]

Similar Datasets

| S-EPMC4772628 | biostudies-literature
| S-EPMC4924447 | biostudies-literature
| S-EPMC4821137 | biostudies-literature
| S-EPMC5098407 | biostudies-literature
| S-EPMC7718386 | biostudies-literature
| S-EPMC5846910 | biostudies-literature
| S-EPMC6738071 | biostudies-literature
| S-EPMC10028591 | biostudies-literature
| S-EPMC9221809 | biostudies-literature
| S-EPMC6324566 | biostudies-literature